SCHEMBL5630150

SCHEMBL5630150

COc1ccc(CNC2=NC(=O)C(=Cc3ccc4ncccc4n3)N2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
APP P05067 2/20 0.39
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
EGFR P00533 1/20 0.37
POLB P06746 1/20 0.37
NR2F2 P24468 1/20 0.37
FABP4 P15090 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CLK4 Q9HAZ1 2/20 0.36
DYRK1A Q13627 2/20 0.36
NCF1 P14598 1/20 0.35
CLK1 P49759 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
CDC7 O00311 1/20 0.35
DAPK3 O43293 1/20 0.35
ROCK2 O75116 1/20 0.35
PRKD3 O94806 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14422272 1.00 NPC1 (0.39) NPC1APPALDH1A1KDM4ERXFP1
SCHEMBL5573752 0.90 APP (0.36) NPC1APPALDH1A1KDM4EFABP4
SCHEMBL5573751 0.90 APP (0.36) NPC1APPALDH1A1KDM4EFABP4
SCHEMBL5631576 0.87 PDE10A (0.38) NPC1APPLMNA
SCHEMBL14422273 0.87 PDE10A (0.38) NPC1APPLMNA
SCHEMBL5574640 0.84 KDM4E (0.39) ALDH1A1KDM4EPOLBLMNATP53
SCHEMBL5570175 0.82 PDE10A (0.34) NPC1LMNACLK4
SCHEMBL5573825 0.81 ELANE (0.40) ALDH1A1RXFP1LMNAEGLN1MAP4K4
SCHEMBL5573823 0.81 ELANE (0.40) ALDH1A1RXFP1LMNAEGLN1MAP4K4
SCHEMBL5574027 0.79 DYRK3 (0.34) NPC1ALDH1A1CLK4DYRK1ACLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084673-A1 1,5-naphthyridine azolinone LIU JIN-JUN 2006-04-20 US claimed
US-7268231-B2 1,5-Naphthyridine azolinone HOFFMANN-LA ROCHE INC. (US) 2007-09-11 US disclosed
US-20060084673-A1 1,5-naphthyridine azolinone LIU JIN-JUN 2006-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084673-A1 1,5-naphthyridine azolinone CDK1, CDK15, CDK14 NPC1 3308/4885APP 4784/4885ALDH1A1 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.